Impact of Drusen Burden on Incidence of Subclinical CNV With OCTA
Atsuro Uchida(Keio University), Justis P. Ehlers(Cleveland Clinic), Aleksandra Rachitskaya(Cleveland Clinic), Sunil K. Srivastava(Cleveland Clinic), Rishi P. Singh(Massachusetts Eye and Ear Infirmary), Peter K. Kaiser(Cleveland Clinic), Jamie Reese(Advanced Imaging Research (United States)), Deepa Manjunath
Cited by 4
Related Papers
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
|The Lancet|2023|343
Phenotype of atopic dermatitis subjects with a history of eczema herpeticum
|Journal of Allergy and Clinical Immunology|2009|264
TENAYA and LUCERNE
|Ophthalmology|2024|173
Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration
|British Journal of Ophthalmology|2014|99
Noninvasive Interference Tear Meniscometry in Dry Eye Patients With Sjögren Syndrome
|American Journal of Ophthalmology|2007|79